{"nct_id":"NCT05572684","title":"A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2022-10-06","start_date_type":"ACTUAL","primary_completion_date":"2025-07","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NXTC"]}